This paper is in the following e-collection/theme issue:

Early Results from COVID-19 Studies (363) Infoveillance and Social Listening (313) JMIR Theme Issue: COVID-19 Special Issue (2554) Infodemiology and Infoveillance (1558) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1139) Depression and Mood Disorders; Suicide Prevention (1691)

Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43850, first published .
Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis

Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis

Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis

Authors of this article:

George Danias1 Author Orcid Image ;   Jacob Appel1 Author Orcid Image
Article Authors Cited by (8) Tweetations (6) Metrics

Journals

  1. Morski L. Invited Commentary on Psychedelic Therapy: A Primer for Primary Care Clinicians. American Journal of Therapeutics 2024;31(2):e183 View
  2. Hughes M, Garcia-Romeu A. Ethnoracial inclusion in clinical trials of psychedelics: a systematic review. eClinicalMedicine 2024;74:102711 View
  3. Modlin N, McPhee T, Zazon N, Sarang M, Hignett R, Pick S, Cleare A, Williamson V, Rucker J. Participants’ Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis. Psychedelic Medicine 2025;3(1):19 View
  4. Barnett B, Vest M, Delatte M, King IV F, Mauney E, Coulson A, Nayak S, Hendricks P, Greer G, Murnane K. Practical considerations in the establishment of psychedelic research programs. Psychopharmacology 2025;242(1):27 View
  5. Cuttler C, Stueber A, Simone J, Mayo L. Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects. Journal of Psychoactive Drugs 2025:1 View
  6. Barnett B, Anand A, Dewey E, Hoffer L, Weleff J. Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019. Psychedelic Medicine 2025 View
  7. Petrovitch D, Hosford S, Littlefield A, Austin-Robillard H. Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample. Drug Science, Policy and Law 2025;11 View
  8. Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P. Harm reduction practises for users of psychedelic drugs: a scoping review. Harm Reduction Journal 2025;22(1) View